Emergent Biosolutions
EBS
EBS
263 hedge funds and large institutions have $2.15B invested in Emergent Biosolutions in 2018 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 103 increasing their positions, 99 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
263
Holders Change
-9
Holders Change %
-3.31%
% of All Funds
6.03%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.07%
New
22
Increased
103
Reduced
99
Closed
30
Calls
$212K
Puts
$348K
Net Calls
-$136K
Net Calls Change
-$1.5M
Top Buyers
| 1 |
BlackRock
New York
|
+$45.5M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.1M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$12.6M |
| 4 |
State Street
Boston,
Massachusetts
|
+$12.1M |
| 5 |
Renaissance Technologies
New York
|
+$10M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$17.3M |
| 2 |
Russell Investments Group
London,
United Kingdom
|
-$13.6M |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$11.9M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$10.5M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$9.11M |
